Publicatiedatum 12-12-2012 | 00:00 Wijzigingsdatum 02-11-2018 | 18:29

Publicaties van Mirjam Kretzschmar, chief science officer Mathematical Disease Modelling bij het RIVM.

Publications in peer reviewed journals

  1. Nock AH, Kretzschmar M, Lipps HJ, Schultz JE. Restoration of membrane exitability by microinjection of cytoplasmic wild-type RNA ribonucleic acid (ribonucleic acid) into Paramecium tetraurelia pawn C mutants. FEMS Microbiology Letters 1982; 13: 275-277.
  2. Kretzschmar M. A renewal equation with a birth-death process as a model for parasitic infections. Journal of Mathematical Biology 1989; 27: 191-221.
  3. Kretzschmar M. Persistent solutions in a model for parasitic infections.  Journal of Mathematical Biology 1989; 27: 549-573.
  4. Diekmann O, Kretzschmar M.  Patterns in the effects of infectious diseases on population growth.  Journal of Mathematical Biology 1991; 29: 539-570.
  5. Adler FR, Kretzschmar M.  Aggregation and stability in parasite-host models. Parasitology 1992; 104: 199-205.
  6. Kretzschmar M, Adler FR.  Aggregated distributions in models for patchy populations.  Theoretical Population Biology 1993; 43: 1-30.
  7. Kretzschmar M. Comparison of an infinite dimensional model for parasitic diseases with a related 2-dimensional system. Journal of Mathematical Analysis and Applications 1993; 176: 235-260.
  8. Kretzschmar M, Nisbet RM risicomanagement (risicomanagement), McCauley E.  A predator-prey model for zooplankton grazing on competing algal populations.  Theoretical Population Biology 1993; 44(1): 32-66.
  9. Morris M, Kretzschmar M.  Measuring Concurrency. Connections 1994; 17(1): 31-34.
  10. Kretzschmar M, Reinking DP, Zessen G van, Brouwers H, Jager JC. The basic reproduction ratio R0 for sexually transmitted diseases in a pair formation model with two types of pairs.  Mathematical Biosciences 1994; 124: 181-205.
  11. Reinking D, van Zessen G, Kretzschmar M, Brouwers H, Jager JC, Stringer P. Social transmission routes of HIV humaan immunodeficientievirus (humaan immunodeficientievirus). A combined sexual network and life course perspective. Patient Education and Counseling 1994; 24: 289-297.
  12. Kretzschmar M. Deterministic and stochastic pair formation models for the spread of sexually transmitted diseases.  Journal of Biological Systems 1995; 3: 789-801.
  13. Kretzschmar M, Reinking DP, Zessen G van, Brouwers H, Jager JC. A network modelling approach for assessing the efficiency of prevention strategies. Journal of Mathematical Sociology 1995; 20: 351-374.
  14. Morris M, Kretzschmar M. Concurrent partnerships and transmission dynamics in networks. Social Networks 1995; 17: 299-318.
  15. Kretzschmar M, Morris M. Measures of concurrency in networks and the spread of infectious disease. Mathematical Biosciences 1996; 133: 165-195.
  16. Kretzschmar M, Duynhoven YTHP van, Severijnen AJ. Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations. American Journal of Epidemiology 1996; 144: 306-317.
  17. Kretzschmar M. Graphs and line graphs as a model for contact patterns. Zeitschrift für Angewandte Mathematik und Mechanik 1996; 76 (Suppl 2): 433-436. 
  18. Kretzschmar M, Duynhoven YTHP van. Effect van preventiestrategieën in model. SOA Bulletin 1996; 17 (5)/18 (1):22-25.
  19. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997; 11: 641-648 (with editorial comment).
  20. Kretzschmar M, Dietz K. The effect of pair formation and variable infectivity on the spread of an infection without recovery. Mathematical Biosciences 1998; 148: 83-113.
  21. Kretzschmar M, Wiessing LG. Modelling the spread of HIV in social networks of injecting drug users. AIDS 1998; 12: 801-811.
  22. Heijden OG van der, Conyn-van Spaendonck MAE, Plantinga AD, Kretzschmar M. A model-based evaluation of the national immunization programme against rubella-infection and congenital rubella syndrome in The Netherlands. Epidemiology and Infection 1998; 121: 653-671.
  23. Wallinga J, Edmunds WJ, Kretzschmar M. Human contact patterns and the spread of airborne infectious diseases. Trends in Microbiology 1999; 7: 372-377.
  24. Boven M van, Melker HE de, Schellekens JFP, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in the Netherlands. Mathematical Biosciences 2000; 164: 161-182.
  25. Morris M, Kretzschmar M. A microsimulation study of the effects of concurrent partnerships on the spread of HIV in Uganda. Mathematical Population Studies 2000; 8: 109-133.
  26. Müller J, Kretzschmar M, Dietz K. Contact tracing in stochastic and deterministic epidemic models. Mathematical Biosciences 2000; 164: 39-64.
  27. Welte R, Kretzschmar M, Leidl R, Hoek JAR van den, Jager JC, Postma MJ. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population based dynamic approach. Sexually Transmitted Diseases 2000; 27: 518-530.
  28. Kretzschmar M. Modellering van transmissie en vaccinatie. Bijblijven 2000; 3: 65-72.
  29. Kretzschmar M. Sexual network structure and STD prevention: a modelling perspective. Sexually Transmitted Diseases 2000; 27: 627-635.
  30. Edmunds WJ, Gay NJ, Kretzschmar M, Pebody R, Wachmann H. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiology and Infection 2000; 125: 635-650.
  31. Kretzschmar M, Welte R, Hoek JAR van den, Postma MJ. A comparative model-based analysis of screening programs for Chlamydia trachomatis infections. American Journal of Epidemiology 2001; 153: 90-101.
  32. Boven M van, Melker HE de, Schellekens JFP, Kretzschmar M. A model based evaluation of the 1996-1997 pertussis epidemic in the Netherlands. Epidemiology and Infection 2001; 127: 73-85.
  33. Kretzschmar M, Wit GA de, Smits LJM, Laar MJW van de. Vaccination against hepatitis B in low endemic countries. Epidemiology and Infection 2002; 128: 229-244.
  34. Welte R, Kretzschmar M, Jager JC, Leidl R, Hoek JAR van den, Postma MJ. Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de seksueel actieve bevolking van Amsterdam. IV Informatievoorziening (Informatievoorziening ). Kosteneffectiviteitsanalyse van screening uitgebreid met de specifieke dynamiek van een infectieziekte. Nederlands Tijdschrift voor Geneeskunde 2002; 146 (11): 514-517.
  35. Kretzschmar M. Mathematical epidemiology of Chlamydia trachomatis infections. The Netherlands Journal of Medicine 2002; 60 (7 Suppl): 35-43.
  36. Teunis PFM., Heijden OG van der, Melker HE de, Schellekens JPF, Versteegh FGA, Kretzschmar M. Kinetics of the IgG Immunoglobulin G (Immunoglobulin G)-antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection 2002; 129: 479-489.
  37. Xiridou M., Geskus R., Wit J de, Coutinho RA, Kretzschmar M. The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS 2003; 17: 1029-1038.
  38. Wallinga J, Teunis PFM, Kretzschmar M. Reconstruction of measles dynamics in a vaccinated population. Vaccine 2003; 21: 2643-2650.
  39. Wiessing LG, Kretzschmar M. Can HIV epidemics among IDUs ‘trigger’ a generalised epidemic? International Journal of Drug Policy 2003; 14: 99-102.
  40. Welte R, Kretzschmar M, Hoek JAR van den, Postma MJ. A population-based dynamic approach for estimating the cost-effectiveness of screening for Chlamydia trachomatis. Sexually Transmitted Infections 2003; 79: 424-429.
  41. Kretzschmar M, Hof S van den, Wallinga J, Wijngaarden J van. Ring vaccination and smallpox control. Emerging Infectious Diseases 2004; 10 (5): 832-841.
  42. Xiridou M, Geskus R, Wit J de, Coutinho RA, Kretzschmar M. Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS 2004; 18: 1311-1320.
  43. Welte R, Postma MJ, Leidl R, Kretzschmar M. Costs and effects of chlamydial screening: dynamic versus static modeling. Sexually Transmitted Diseases 2005; 32 (8): 474-483.
  44. Boven M van, Mooi FR, Schellekens JFP, Melker H de, Kretzschmar M. Pathogen adaptation under imperfect vaccination: implications for pertussis. Proceedings of the Royal Society of London B: Biological Sciences 2005; 272 (1572): 1617-1624.
  45. Xiridou M, Kretzschmar M, Geskus R. Competition of pathogen strains leading to infection with variable infectivity and the effect of treatment. Mathematical Biosciences 2005; 197: 153-172.
  46. Wallinga J, Heijne J, Kretzschmar M. A measles epidemic threshold in a highly vaccinated population. PLoS Plos One (Plos One) Medicine 2005; 2 (11): e316.
  47. Marschall T, Krämer A, Prüfer-Krämer L, Mikolajczyk R, Kretzschmar M. Erhöhen Migrationen aus hohen und mittleren Endemiegebieten die Hepatitis B-Prävalenz in Deutschland?Epidemiologische Schätzung der HBsAg hepatitis B surface antigeen (hepatitis B surface antigeen)-Prävalenz bei verschiedenen erwachsenen Bevölkerungsgruppen. Deutsche Medizinische Wochenschrift 2005; 48: 2753-2759.
  48. Melker HE, Versteegh FGA, Schellekens JFP, Teunis PFM, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. Journal of Infection 2006; 53: 106-113.
  49. Wallinga J, Teunis P, Kretzschmar M. Using social contact data to estimate age-specific transmission parameters for infectious respiratory spread agents. American Journal of Epidemiology 2006; Nov 15;164(10):936-44.
  50. Andersen B, Gundgaard J, Kretzschmar M, Olsen J, Welte R, Østergaard L. Prediction of costs, effectiveness, and disease control of a population based program using home sampling for diagnosis of urogenital Chlamydia trachomatis infections. Sexually Transmitted Diseases 2006; 33(7): 407-415.
  51. Kretzschmar M, Wallinga J, Teunis P, Xing S, Mikolajczyk R. Frequency of adverse events after vaccination with different vaccinia strains. PLoS Medicine 2006; 3 (8): e272 (Correction: PLoS Medicine 2006; 3(10): e429).
  52. Kretzschmar M, Wallinga J, Coutinho RA. Wiskundige modellering voor bestrijding van infectieziekten. Nederlands Tijdschrift voor Geneeskunde 2006; 150 (36): 1965-1970.
  53. Mikolajczyk RT Real Time (Real Time), Sagel U, Bornemann R, Krämer A, Kretzschmar M. A statistical method for estimating the proportion of cases resulting from cross-transmission of multiresistant pathogens in an intensive care unit. Journal of Hospital Infections 2007; 65 (2): 149-155.
  54. Kretzschmar M, Wallinga J. Editorial: Networks in epidemiology. Mathematical Population Studies 2007; 14 (4): 203-209.
  55. Akmatov M, Kretzschmar M, Krämer A, Mikolajczyk RT. Determinants of childhood immunization coverage in Kazakhstan in a period of societal change: implications for vaccination policies. Vaccine 2007; 25: 1756-1763.
  56. Mikolajczyk R, Akmatov M, Rastin S, Kretzschmar M. Social contacts of school children and the transmission of respiratory spread pathogens. Epidemiology and Infection 2008; Jun;136(6):813-22.
  57. Mikolajczyk R, Kretzschmar M. Collecting social contact data in the context of disease transmission: prospective and retrospective study designs. Social Networks 2008; 30: 127-135.
  58. Kretzschmar M, Wit GA de. Universal hepatitis B vaccination. Lancet Infectious Diseases 2008; 8 (2): 85-87.
  59. Rossum TGJ van, Melker HE de, Houweling H, Voordouw ACG, Meijer CJLM, Helmerhorst TJM, Kretzschmar M, Berkhof J, Noordaa J van der. Vaccins tegen humaan papillomavirus (HPV humaan papillomavirus (humaan papillomavirus)); tussen registratie en implementatie. Nederlands Tijdschrift voor Geneeskunde 2008; 152 (17): 987-992.
  60. Kretzschmar M, Wiessing L. New challenges for mathematical and statistical modelling of HIV and HCV hepatitis C virus (hepatitis C virus) in injecting drug users. AIDS 2008; 22(13): 1527-1537.
  61. Mikolajczyk RT, Akmatov MK, Stich H, Krämer A, Kretzschmar M. Association between acculturation and childhood vaccination coverage in migrant populations: a population based study from a rural region in Bavaria, Germany. International Journal of Public Health 2008; 53(4):180-7.
  62. Akmatov M, Kretzschmar M, Krämer A, Mikolajczyk RT. Timeliness of vaccination and its effects on fraction of vaccinated population. Vaccine 2008; 26: 3805-3811.
  63. Kretzschmar M, Zhang W, Mikolajczyk RT, Wang L, Sun X, Krämer A, Lv F. Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infectious Diseases 2008 Aug 4; 8:108.
  64. Marschall T, Kretzschmar M, Mangen MJJ, Schalm S. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. European Journal of Gastroenterology & Hepatology 2008; 20 (12): 1214-25.
  65. Sutton A, Hope VD, Mathei C, Mravcik V, Sebakova H, Vallejo F, Suligoi B, Brugal MT, Ncube F, Wiessing LG, Kretzschmar M. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union – A modelling study. Journal of Viral Hepatitis 2008; 15 (11): 809-816.
  66. Heijne JCM, Teunis P, Morroy G, Wijkmans C, Oostveen S, Duizer E, Kretzschmar M, Wallinga J. Impact of enhanced hygiene measures on change in reproduction number during an outbreak of norovirus. Emerging Infectious Diseases 2009 Jan;15(1):24-30.
  67. Low N, Heijne JCM, Kretzschmar M. Use of mathematical modeling to inform chlamydia screening policy decisions.  Journal of  Infectious Diseases 2009; 199 (5): 767-768.
  68. Akmatov MK, Mikolajczyk RT, Kretzschmar M, Krämer A. Attitudes and beliefs of parents about childhood vaccinations in post-Soviet countries: example of Kyrgyzstan. The Pediatric Infectious Disease Journal 2009; 28(7):637-40.
  69. Kretzschmar M, Mangen MJJ, Laar, MJW van de, Wit GA de. Model based analysis of hepatitis B vaccination strategies in the Netherlands. Vaccine 2009 Feb 18;27(8):1254-60.
  70. Mikolajczyk RT, Kauermann G, Sagel U, Kretzschmar M. Mixture model to assess the extent of cross-transmission of multi-resistant pathogens in hospitals. Infection Control and Hospital Epidemiology 2009; Aug;30(8):730-6.
  71. Kuate S, Mikolajczyk RT, Forgwei G, Tih PM, Welty TK,  Kretzschmar M. Regional differences and time trends in the prevalence of HIV infection among women attending antenatal clinics in two provinces in Cameroon. J AIDS 2009; 52 (2): 258-264.
  72. Hahné S, Wörmann T, Kretzschmar M. Migrants and hepatitis B: new strategies for secondary prevention needed. European Journal of Public Health 2009; Aug;19(4):439.
  73. Bernard H, Fischer R, Mikolajczyk R, Kretzschmar M, Wildner M. Nurses’ contacts and potential for infectious disease transmission. Emerging Infectious Diseases 2009 Sept; 15 (9): 1438-44.
  74. Kretzschmar M, Turner KME, Barton PM, Edmunds WJ, Low N. Predicting the population impact of Chlamydia screening programs: comparative mathematical modeling study. Sexually Transmitted Infections 2009 Sept; 85(5):359-66.
  75. Kretzschmar M, Mikolajczyk RT. Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases. PLoS One 2009; Jun 17; 4(6):e5931.
  76. Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L. Can HCV prevalence be used as a measure of injection-related HIV-risk in populations of injecting drug users? An ecological analysis. Addiction 2010 Feb; 105 (2): 311-8
  77. Kretzschmar M, White RG, Caraël M. Concurrency is more complex than it seems. AIDS. 2010 Jan 16;24(2):313-5.
  78. Bijkerk P, Lier A van, Vliet JA van, Kretzschmar M. Effecten van vergrijzing op infectieziekten in Nederland. Nederlands Tijdschrift voor Geneeskunde 2010; 154:A1613.
  79. Boven M van, Kretzschmar M, Wallinga J, O’Neill PD, Wichmann O, Hahne S. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J Roy Soc Interface 2010; 6;7(52):1537-44.
  80. Kretzschmar M, Teunis PFM, Pebody RG. Estimating incidence and reproduction numbers of pertussis using serological and social contact data from five European countries. PLoS Medicine 2010, 7(6): e1000291.
  81. Kretzschmar M, Gomes GM, Coutinho RA, Koopman JS Joint Strike Fighter (Joint Strike Fighter). Unlocking pathogen genotyping information for public health by mathematical modeling. Trends in Microbiology 2010; 18(9):406-12.
  82. Teunis P, Brienen N, Kretzschmar M. High infectivity and pathogenicity of  influenza A virus via different transmission routes. Epidemics 2010; 2: 215–222.
  83. de Vries R, Kretzschmar M, Schellekens JFP, Versteegh FGA, Westra TA, et al. 2010 Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model. PLoS ONE 2010; 5(10): e13392.
  84. Krumkamp R, Kretzschmar M, Rudge JW, Ahmad A, Hanvoravongchai P, Westenhoefer J, Stein M, Putthasri W, Coker R. Health service resource needs for pandemic influenza in developing countries: a linked transmission dynamics, interventions and resource demand model. Epidemiology and Infection 2011; 139(1):59-67.
  85. Wijngaard CC van den, Dijkstra F, Pelt W van, Asten L van, Kretzschmar M, Schimmer B, Nagelkerke NJD, Vellema  P, Donker G, Koopmans MPG mpg (mpg). In search of hidden Q-fever outbreaks: linking syndromic hospital clusters to infected goat farms. Epidemiology and Infection 2011; 139(1):19-26.
  86. Heijne JCM, Althaus CL, Herzog SA, Kretzschmar M, Low N. The role of re-infection and partner notification in the efficacy of Chlamydia screening programs. Journal of Infectious Diseases 2011; 203(3):372-7.
  87. van Asten L, Siebenga J, van den Wijngaard C, Verheij R, van Vliet H, Kretzschmar M, Boshuizen H, van Pelt W, Koopmans M. Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics. Epidemiology 2011; May;22(3):336-43.
  88. Wijngaard CC van den, Pelt W van, Nagelkerke NJD, Kretzschmar M, Koopmans MPG. Evaluation of syndromic surveillance in the Netherlands: its added value and recommendations for implementation. Euro Surveill. 2011 Mar 3;16(9). pii: 19806.
  89. Del Fava E, Kasim AS, Usman M, Shkedy Z,  Hens N, Aerts M, Bollaerts K, Scalia Tomba G, Vickerman P, Sutton AJ, Wiessing L, Kretzschmar M. Joint Modeling of HCV and HIV in Italy Using Time Series of Cross-Sectional Prevalence Data. Statistical Communications in Infectious Diseases 2011; Vol. 3: Iss. 1, Article 1.
  90. Reijn E, Swaan C, Kretzschmar M, Steenbergen JE van. Analysis of timeliness of infectious disease notifications in the Netherlands. BMC Public Health 2011, 11:409.
  91. Del Fava E, Shkedy Z,  Hens N, Aerts M, Suligoi B, Camoni L, Vallejo F, Wiessing L, Kretzschmar M. Joint modeling of HCV and HIV co-infection among injecting drug users in Italy and Spain using individual cross-sectional data. Statistical Communications in Infectious Diseases 2011; Vol. 3: Iss. 1, Article 3.
  92. Suijkerbuijk A, Broek IVF van den, Brouwer H, Rolleghem A van, Joosten H, Verheij R, Sande MAB van der, Kretzschmar M.  Usefulness of primary care electronic networks to assess the incidence of chlamydia, diagnosed by general practitioners. BMC Family Practice 2011, 12:72
  93. Braks M, van der Giessen J, Kretzschmar M, van Pelt W, Scholte EJ, Reusken C, Zeller H, van Bortel W, Sprong H. Towards an integrated approach in surveillance of vector-borne diseases in Europe. Parasites and Vectors 2011 Oct 3;4(1):192.
  94. Swaan CM, Appels R, Kretzschmar M, Steenbergen JE van. Timeliness of contact tracing among flight passengers for Pandemic Influenza A/H1N1 2009. BMC Infectious Diseases 2011 Dec 28; 11(1): 355.
  95. Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJLM, Berkhof J, Wallinga J. Sex-specific immunization for the control of sexually transmitted infections: the case of human papillomavirus vaccination.  PLoS Med 2011 Dec; 8(12): e1001147.
  96. Wielders CCH, Lier EA van, Klooster TM van’t, Gageldonk-Lafeber AB van, Wijngaard CC van den, Haagsma JA, Donker GA, Meijer A, Hoek W van der, Lugner AK,  Kretzschmar M, Sande MAB van der. The burden of 2009 pandemic influenza A(H1N1)  in the Netherlands. European Journal of Public Health 2012 Feb;22(1):150-7.
  97. Althaus CL, Turner KME, Schmid BV, Heijne JCM, Kretzschmar M, Low N. Transmission of Chlamydia trachomatis through sexual partnerships: a comparative study between models and data.  J Roy Soc Interface 2012 Jan 7;9(66):136-46.
  98. Matser AA, Urbanus AT, Geskus RB Robertson-Berger (Robertson-Berger), Kretzschmar MEE, Coutinho RA, Xiridou M, Prins M. The effect of HCV treatment and HIV coinfection on the future disease burden of hepatitis C among injecting drug users in Amsterdam.  Addiction 2012 Mar;107(3):614-623.
  99. Sutton AJ, House T, Hope VD, Ncube F, Wiessing L, Kretzschmar M. Modelling HIV in the injecting drug user population and the male homosexual population in a developed country context. Epidemics. 2012 Mar;4(1):48-56.
  100. Castro-Sánchez A, Shkedy Z, Hens N, Aerts M, Geskus R, Prins M, Wiessing L, Kretzschmar M. Estimating the force of infection for HCV in injecting drug users using interval-censored data. Epidemiol Infect. 2012 Jun;140(6):1064-74.
  101. Kretzschmar ME, Schim-van der Loeff MF, Coutinho RA. Elimination of HIV by test and treat: a phantom of wishful thinking? AIDS 2012 Jan 14; 26(2): 247-8.
  102. Mikolajczyk RT, Horn J, Damm O, Kaufmann AM, Kretzschmar ME. Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections. J Natl Cancer Inst. 2012 Jan 18;104(2):163.
  103. Hahné SJ, DE Melker HE, Kretzschmar M, Mollema L, van der Klis FR, van der Sande MA, Boot HJ. Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiol Infect. 2012 Aug;140(8):1469-80.
  104. Heijne JC, Rondy M, Verhoef L, Wallinga J, Kretzschmar M, Low N, Koopmans M,  Teunis PFM.  The role of health care workers in the transmission of norovirus during an outbreak. Epidemiology 2012 Mar;23(2):277-284.
  105. Van den Wijngaard CC, van Asten L, Koopmans M, Pelt W van, Nagelkerke N, Wielders C, Lier A van, Hoek W van der, Meijer A, Donker G, Dijkstra F, Harmsen C, Sande M van der, Kretzschmar M. Comparing Pandemic to  Seasonal Influenza Mortality: Moderate Impact Overall but High Mortality in Young Children.  PLoS One 2012; 7(2):e31197.
  106. Swart AN, Tomasi M, Kretzschmar M, Havelaar AH, Diekmann O. The protective effects of temporary immunity under imposed infection pressure. Epidemics. 2012 Mar; 4(1):43-7.
  107. Vos AS de, van der Helm J, Prins M, Kretzschmar M. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. Epidemics 2012 Jun;4(2):57-67.
  108. Kretzschmar M, Satterwhite CL, Leichliter JS, Berman SM. Effects of screening and partner notification on Chlamydia prevalence in the United States: a modeling study. Sexually Transmitted Diseases 2012 May; 39(5):325-31.
  109. Kretzschmar M , Mangen MJJ, Pinheiro P, Jahn B, Fèvre E, Longhi S, Lai T, Havelaar A, Stein C, Cassini A,  Kramarz P, for the BCoDE Burden of Communicable Diseases in Europe (Burden of Communicable Diseases in Europe) consortium.  New methodology for estimating the burden of infectious diseases in Europe. PLoS Medicine 2012; 9(4): e1001205.
  110. Caraël M, Kretzschmar M. Measuring concurrent partnerships: back on track. Editorial commentary. AIDS 2012; 26:1027–1029.
  111. Asten L van, Wijngaard C van den, Pelt W van,  Kassteele J van de, Meijer A, Hoek W van der,  Kretzschmar M, Koopmans M. Estimating the numbers of deaths attributable to 9 common infectious pathogens adjusted for seasonality and temperature: significant effects of influenza A, respiratory syncytial virus, influenza B, norovirus and parainfluenza. Journal of Infectious Diseases 2012; Sep;206(5):628-39.
  112. Schmid BV, Kretzschmar M. Determinants of sexual network structure and their impact on cumulative network measures. PLoS Computational Biology 2012; 8(4): e1002470.
  113. Bonačić Marinović AA, Swaan C, Wichmann O, van Steenbergen J, Kretzschmar M. Effectiveness and timing of vaccination during school measles outbreak. Emerging Infectious Diseases 2012 Sept; 18 (9): 1405-1413.
  114. Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, Brisson M; ISPOR-SMDM Modeling Good Research Practices Task Force. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value Health. 2012 Sep;15(6):828-34.
  115. Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, Brisson M; On Behalf of the ISPOR-SMDM Modeling Good Research Practices Task Force. Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5. Med Decis Making. 2012 Sep;32(5):712-721.
  116. Kretzschmar M, Caraël M. Is concurrency driving HIV transmission in sub-Saharan African sexual networks? The significance of sexual partnership typology.  AIDS and Behavior 2012, Oct;16(7):1746-52
  117. van den Broek IVF, van Bergen JEAM, Brouwers EEHG, Fennema JSA, Götz HM, Hoebe CJPA, Koekenbier RH, Kretzschmar M, Over EAB, Schmid BV, Pars LL, van Ravesteijn SM, van der Sande MAB, de Wit GA, Low N, Op de Coul ELM Expertmeeting Luchtkwaliteitmodellering (Expertmeeting Luchtkwaliteitmodellering). Effectiveness of yearly register-based screening for chlamydia in the Netherlands: cluster randomised controlled trial. Brit Med J 2012; Jul 5;345:e4316.
  118. Leung KY, Kretzschmar M, Diekmann O. Dynamic concurrent partnership networks incorporating demography. Theor Popul Biol. 2012 Nov;82(3):229-39.
  119. Stein ML, Rudge J, Coker R, van der Weijden C,  Krumkamp R, Hanavorangchai P,  Chavez I, Putthasri W, Kretzschmar M, Timen A. Development of a resource modelling tool to support decision makers in pandemic influenza preparedness: The AsiaFluCap Simulator.  BMC Public Health 2012; Oct 12;12(1):870.
  120. McDonald S, van Lier A, Plass D, Kretzschmar M. The impact of population aging on the estimated future burden of infectious diseases: Example of hepatitis B and seasonal influenza in the Netherlands. BMC Public Health 2012 Dec 5; 12(1):1046.
  121. Rondy M, Wiessing L, Hutchinson S, Mathei C, Mathis F, Mravcik V, Norden L, Rosinska M, Scutelniciuc O, Suligoi B, Vallejo F, Veen M van, Kretzschmar M. Hepatitis C prevalence among injecting drug users in Europe, 1990-2007: Assessment of the impact of study recruitment setting. Epidemiology and Infection 2013 Mar;141(3):563-72.
  122. Safan M, Kretzschmar M, Hadeler KP. Dynamics and vaccination based control of infections in SIRS models with reinfection: special reference to pertussis. Journal of Mathematical Biology 2013 Nov;67(5):1083-110.
  123. Oei W, Janssen MP, Poel CL van der, Steenbergen JE van, Rehmet S, Kretzschmar ME. Modeling the transmission risk of emerging infectious diseases through blood transfusion. Transfusion 2013 Jul;53(7):1421-8.
  124. van der Weijden CP, Stein ML, Jacobi AJ, Kretzschmar ME, Reintjes RR relatieve risico's (relatieve risico's), van Steenbergen JE, Timen AA. Choosing pandemic parameters for pandemic preparedness planning: A comparison of pandemic scenarios prior to and following the influenza A(H1N1) 2009 pandemic. Health Policy. 2013 Jan;109(1):52-62.
  125. Teunis PFM, Schimmer B, Notermans DW, Leenders ACAP, Wever PC, Kretzschmar MEE,  Schneeberger PM. Time course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiology and  Infection 2013 Jan;141(1):62-73.
  126. Teunis P, Heijne J, Sukhrie F, van Eijkeren J, Koopmans M, Kretzschmar M. Infectious disease transmission as a forensic problem: who infected whom? J Roy Soc Interface 2013 Feb 6;10(81):20120955
  127. Heijne J, Herzog SA, Althaus CL, Low N, Kretzschmar M. Reproduction numbers for a curable sexually transmitted infection.  J Theor Biol 2013; Aug 21;331:38-47.
  128. Vos A de, van der Helm J, Matser A, Prins M, Kretzschmar M. Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? Addiction 2013 Jun;108(6):1070-81.
  129. Mangen MJ, Plass D, Havelaar AH, Gibbons CL, Cassini A, Mühlberger N, van Lier A, Haagsma JA, Brooke RJ, Lai T, de Waure C, Kramarz P, Kretzschmar ME; BcoDE consortium. The Pathogen- and Incidence-Based DALY Disability Adjusted Life Year (Disability Adjusted Life Year) Approach: An Appropriate Methodology for Estimating the Burden of Infectious Diseases. PLoS One 2013 Nov 20;8(11):e79740.
  130. Schmid BV, Over E, van den Broek I, Op de Coul E, van Bergen J, Fennema H, Gotz H, Hoebe C, de Wit GA, van der Sande MAB, Kretzschmar M. Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates. PLoS One 2013; 8(3): e58674.
  131. McDonald S, Mangen MJJ, Suijkerbuijk A, Colzani E, Kretzschmar M. Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands. BMC Infectious Diseases 2013 Mar 5; 13(1):120.
  132. Horn J, Damm O, Kretzschmar MEE, Delere Y, Wichmann O, Kaufmann AM, Garbe E, Krämer A, Greiner W, Mikolajczyk RT. Estimating the long-term effects of HPV vaccination in Germany. Vaccine 2013 May 1;31(19):2372-80.
  133. Norden L, van Veen M, Lidman C, Todorov I, Guarita B, Kretzschmar M, Wiessing L. Hepatitis C among injecting drug users is two times higher in Stockholm, Sweden than in Rotterdam, the Netherlands. Substance Use and Misuse 2013 Dec; 48(14):1469-74.
  134. Xiridou M, van Houdt R, Hahne S, Coutinho R, van Steenbergen J, Kretzschmar M. Hepatitis B vaccination of men who have sex with men in the Netherlands: should we vaccinate more men, younger men, or high-risk men?  Sexually Transmitted Infections 2013 Dec; 89(8):666-71.
  135. Kretzschmar M, Schim van der Loeff M, Birrell P, De Angelis D, Coutinho R. Prospects of elimination of HIV with test and treat strategy. Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15538-43.
  136. Rijckevorsel G van, Whelan J, Kretzschmar M, Siedenburg E, Sonder G, Geskus R, Countinho R, Hoek A van den. Targeted Vaccination Program Successful in Reducing Acute Hepatitis B In Men Having Sex With Men in Amsterdam, The Netherlands. Journal of Hepatology 2013 Dec;59(6):1177-83.
  137. Vos de AS, Kretzschmar M. The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users. J Theor Biol 2013 Sep 21; 333:126-34.
  138. Brooke RJ, Kretzschmar MEE, Mutters NT, Teunis PFM. Human dose response relation for airborne exposure to Coxiella burnetii. BMC Infectious Diseases 2013 Oct 21;13(1):488.
  139. Plass D, Mangen MJJ, Krämer A, Pinheiro P, Gilsdorf A, Krause G, Gibbons C, van Lier A,  McDonald SA, Brooke RJ, Cassini A, Kramarz P, Kretzschmar MEE. The disease burden of Hepatitis B , Influenza, Measles and Salmonellosis  in Germany – first results of the Burden of Communicable Diseases in Europe Study.  Epidemiol Infect 2014; [published ahead of print].
  140. Brooke RJ, van Lier A, Donker G, van den Hoek W, Kretzschmar M. Comparing the impact on population health of two simultaneous outbreaks of emerging infectious diseases in the Netherlands, 2009, using disability adjusted life years. Epidemiology and Infection 2014; [published ahead of print].
  141. McDonald SA, Presanis AM, De Angelis D, van den Hoek W, Hooiveld M , Donker G, Kretzschmar ME. An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands. Influenza and other Respiratory Viruses 2014 Jan;8(1):33-41.
  142. Oei W, Kretzschmar MEE, van der Poel CL, Zaaijer H, Coutinho R, Janssen MP. Estimating the transfusion transmission risk of Q fever. Transfusion 2014; [published ahead of print].
  143. Stein ML, Steenbergen JE van, Chanyasanha C, Tipayamongkholgul M, Buskens V, Heijden PGM van der, Sabaiwan W, Bengtsson L, Lu X, Thorson AE alveolaire echinokokkose (alveolaire echinokokkose), Kretzschmar MEE. Online respondent-driven sampling for studying contact patterns relevant for the spread of close-contact pathogens: a pilot study in Thailand.  PLoS One 2014 Jan 8;9(1):e85256.
  144. Gibbons CL, Mangen MJJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, Peterson K, Stuurman A, Cassini A, Fevre EM, Kretzschmar MEE. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health 2014 Feb 11;14(1):147.
  145. Matser AA, Heijman T, Geskus R, de Vries H, Kretzschmar M, Speksnijder A, Xiridou M, Fennema J, Schim van der Loeff M. Perceived HIV status is a key determinant of unprotected anal intercourse within partnerships of men who have sex with men in Amsterdam. AIDS Behav. 2014 Jun 12. [Epub ahead of print]
  146. Matser A, Heiligenberg M, Geskus R, Heijman T, Low N, Kretzschmar M, Schim van der Loeff M. The importance of partnership factors and individual factors associated with absent or inconsistent condom use in heterosexuals: a cross-sectional study. Sex Transm Infect. 2014 Jun;90(4):325-31.
  147. Burns DN, Degruttola V, Pilcher CD, Kretzschmar M, Gordon CM, Flanagan EH, Duncombe C, Cohen MS Multiple Sclerose (Multiple Sclerose ). Toward an Endgame: Finding and Engaging People Unaware of Their HIV-1 Infection in Treatment and Prevention.  AIDS Res Hum Retroviruses. 2014 Mar;30(3):217-24.
  148. Van Asten L, Fanoy E, Koopmans M, Hooiveld M, van den Wijngaard C, Kretzschmar M. Syndroomsurveillance: een vinger aan de pols van de volksgezondheid. Nederlands Tijdschrift voor Geneeskunde 2014; 158(0):A7415.
  149. de Vos AS, Prins M, Coutinho RA, van der Helm JJ, Kretzschmar ME. Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study. AIDS. 2014 Mar 27;28(6):911-8.
  150. Stein ML, Rump BO, Kretzschmar ME, van Steenbergen JE.  Social networking sites as a tool for contact tracing: urge for ethical framework for normative guidance. Public Health Ethics 2014; 7(1):57-60.
  151. Leung K, Kretzschmar M, Diekmann O. SI infection on a dynamic partnership network: characterization of R0. Journal of Mathematical Biology 2014; in press.
  152. Oostvogels AJJM, De Wit GA,  Jahn B, Cassini A, Colzani E, de Waure C, Kretzschmar MEE, Siebert U, Mühlberger N, Mangen MJJ. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review.  Submitted.
  153. de Graaf WF, Kretzschmar MEE, Teunis PFM, Diekmann O. A two-phase within host model for immune boosting and waning applied to serological profiles of pertussis. Submitted.

Publications in books, proceedings and reports

  1. Kretzschmar M. Eine Erneuerungsgleichung mit einem Geburt-Tod Prozeß als Modell für Parasitosen. Dissertation, University of Tübingen, 1987.
  2. Kretzschmar M.  Age-structured populations with multi-type parasitic infections. In Tautu P. (ed.)  Stochastic Modelling in Biology, World Scientific Publishing Co., Singapur, 1990; pp. 340-359.
    156. Kretzschmar M, Reinking DP, Brouwers H, Zessen G van, Jager JC.  Network models: from paradigm to mathematical tool.  In Kaplan E.H., Brandeau M. (eds.): Modeling the AIDS Epidemic, Raven Press, New York, 1994; pp. 561-583.
  3. Kretzschmar M. The spread of a STD on a dynamic network of sexual contacts. In V. Isham and G. Medley (eds.) Models for Infectious Human Diseases: Their Structure and Relation to Data, Cambridge University Press, Cambridge 1996; pp. 281-282. 
  4. Kretzschmar M, Duynhoven YTHP van. Effecten van preventiestrategieën voor gonorroe en infecties met Chlamydia trachomatis gemodelleerd. In: Volksgezondheid Toekomst Verkenning 1997, IV. Effecten van preventie. L.J. Gunning-Schepers, J. Jansen (eds.), Elsevier/De Tijdstroom 1997; p. 271.
  5. Kretzschmar M, Duynhoven YTHP van. Effecten van preventiestrategieën voor gonorroe en infecties met Chlamydia trachomatis. In: Volksgezondheid Toekomst Verkenning 1997, VII. Gezondheid en zorg in de toekomst. A. van den Berg Jeths (ed.), Elsevier/De Tijdstroom 1997; pp. 143-148.
  6. Kretzschmar M. Modelling network structure: implications for spread and prevention of HIV-infection. In J.-P. Moatti, Y. Souteyrand, A. Prieur, P. Aggleton, and T. Sandfort (eds.) AIDS in Europe: new challenges for the social sciences.  London, Routledge, 2000; pp. 234-246.
  7. Kretzschmar M. Modelling infectious diseases and other health consequences: predicting future morbidity consequences and spread of HIV, hepatitis B, and hepatitis C. In C Godfrey, L Wiessing, and R Hartnoll (eds.) “Modelling drug use: methods to quantify and understand hidden processes”. EMCDDA Monograph 6, Luxembourg: Office of Official Publications of the European Communities, 2001; pp. 169-182.
  8. Kretzschmar M. Calculating and estimating the basic reproduction number of hepatitis B in a heterogeneous population. Proceedings – Manuscripts of Invited Paper Presentations, XXIst International Biometric Conference 2002, Freiburg, Germany; pp. 175-186.
  9. Eichner M, Kretzschmar M. Mathematische Modelle in der Infektionsepidemiologie. In A. Krämer, R. Reintjes (eds.) Infektionsepidemiologie. Springer Verlag, Frankfurt, 2003.
  10. Pebody R, Kretzschmar M. Grundlagen und Praxis von Impfung. In A. Krämer, R. Reintjes (eds.) Infektionsepidemiologie. Springer Verlag, Frankfurt, 2003.
  11. Kretzschmar M, Reintjes R, Wille L. Analysesoftware für die Infektionsepidemiologie. In A. Krämer, R. Reintjes (eds.) Infektionsepidemiologie. Springer Verlag, Frankfurt, 2003.
  12. Xiridou M, Kretzschmar M, Geskus R, de Wit J, Coutinho RA. Steady and casual partners as sources of HIV infection among homosexual men in Amsterdam. In: "Mathematical Modelling and Computing in Biology and Medicine. 5th ESMTB Conference 2002" (Ed. V. Capasso), The MIRIAM Project Series, Esculapio Publishers, Bologna, 2003, p. 477-482.
  13. Kretzschmar M, Wiessing LG. Modelling of transmission of hepatitis C in injecting drug users. In: JC Jager, W Limburg, M Kretzschmar, M Postma, LG Wiessing (eds.)   “Hepatitis C and injecting drug use: impact, costs and policy options”, EMCDDA Monographs 7, Luxemburg: Office for the Official Publications of the European Community, 2004.
  14. Kretzschmar M, Wallinga J, Teunis P, Xing S, Mikolajczyk R. Adverse effects of smallpox vaccination: new analysis of old data. In: Becker N, Dietz K, Keiding N. Conference on “Design and Analysis of Infectious Diseases Studies”, Oberwolfach Reports 2004; 1 (4): 2591-2652.
  15. Kretzschmar M. Infectious Disease Modeling. In: Kris Heggenhougen and Stella Quah, editors International Encyclopedia of Public Health, Vol 3. San Diego: Academic Press; 2008. pp. 569-576.
  16. Bijkerk P, van Lier A, van Vliet H, Kretzschmar M. Staat van Infectieziekten in Nederland, 2008. RIVM report 210211005/2009, Bilthoven.
  17. Kretzschmar M, Wallinga J. Mathematical models in infectious disease epidemiology. In: Modern Infectious Disease Epidemiology. Concepts, Methods, Mathematical Models, and Public Health. Series: Statistics for Biology and Health. Krämer, Alexander; Kretzschmar, Mirjam; Krickeberg, Klaus (Eds.). Springer Verlag, New York; 2010.
  18. Akmatov M, Krämer A, Kretzschmar M. Principles of infectious disease epidemiology. In: Modern Infectious Disease Epidemiology. Concepts, Methods, Mathematical Models, and Public Health. Series: Statistics for Biology and Health. Krämer, Alexander; Kretzschmar, Mirjam; Krickeberg, Klaus (Eds.). Springer Verlag, New York; 2010.
  19. Pebody R, Kretzschmar M. Principles and practice of vaccinology. In: Modern Infectious Disease Epidemiology. Concepts, Methods, Mathematical Models, and Public Health. Series: Statistics for Biology and Health. Krämer, Alexander; Kretzschmar, Mirjam; Krickeberg, Klaus (Eds.). Springer Verlag, New York; 2010.
  20. Kretzschmar M. Infectious Disease Modelling. In: Epidemiology and Demography in Public Health, edited by Japhet Killewo, H. Kristian Heggenhougen, and Stella R. Quah. Elsevier, 2010; pp 167-173.
  21. Bijkerk P, Roede BM, van Lier EA, Kretzschmar M. Staat van Infectieziekten in Nederland, 2009. RIVM report 210211006/2010, Bilthoven.
  22. Horn J, Damm O, Kretzschmar M, Deleré Y, Wichmann O, Kaufmann AM, Krämer A, Greiner W,  Mikolajczyk R. Langfristige epidemiologische und ökonomische Auswirkungen der HPV Impfung in Deutschland. Abschlussbericht. Robert Koch Institut, Berlin 2011.
  23. Bijkerk P, van Lier EA, Swaan C, Kretzschmar M. Staat van Infectieziekten in Nederland, 2010. RIVM report 210211007/2011, Bilthoven.
  24. Bijkerk P, van der Plas SM, van Asten L, Fanoy EB, Kroneman A, Kretzschmar M. Staat van Infectieziekten in Nederland, 2011. RIVM report 210211008/2012, Bilthoven.
  25. Kretzschmar M. "Mathematical Tools for Understanding Infectious Disease Dynamics. O. Diekmann, H. Heesterbeek, and T. Britton (2012). Princeton: Princeton University Press. 502 pages, ISBN: 978‐0‐691‐1‐5539‐5." Biometrical Journal 56.1 (2014): 176-177.

 

Books, proceedings and reports handled as an editor

  1. Hepatitis C and injecting drug use: impact, costs and policy options. Editors: JC Jager, W Limburg, M Kretzschmar, M Postma, LG Wiessing. EMCDDA Monographs 7, Luxemburg: Office for the Official Publications of the European Community, 2004.
  2. Networks in Epidemiology. Special Issue of Mathematical Population Studies. Guest editors: M Kretzschmar, J Wallinga. 2007; 14 (4).
  3. Mathematical Modeling of Biological Systems, Volume II. Epidemiology, Evolution and Ecology, Immunology, Neural Systems and the Brain, and Innovative Mathematical Methods. Editors: A. Deutsch, R. Bravo de la Parra, R. de Boer, O. Diekmann, P. Jagers, E. Kisdi, M. Kretzschmar, P. Lansky and H. Metz. Birkhäuser, Boston, 2008.
  4. Modern Infectious Disease Epidemiology. Concepts, Methods, Mathematical Models, and Public Health. Series: Statistics for Biology and Health. Krämer, Alexander; Kretzschmar, Mirjam; Krickeberg, Klaus (Eds.). Springer Verlag, New York; 2010.
  5. European Centre for Disease Prevention and Control. Methodology protocol for estimating burden of communicable diseases. Stockholm: ECDC European Centre for Disease Prevention and Control (European Centre for Disease Prevention and Control ); 2010.
  6. Straif-Bourgeois S, Ratard R, Kretzschmar M. Infectious Disease Epidemiology. In Iris Pigeot and Wolfgang Ahrens (eds.) Handbook of Epidemiology. Springer Verlag, 2014; pp 2041-2119.
  7. Mangen M-JJ, Plass D, Kretzschmar M (eds). Estimating the current and future burden of communicable diseases in the European Union and EEA/EFTA. RIVM report 210474001/2014, Bilthoven 2014.